Vol.

No.

December 19, 2014Dec 19, 2014

Free

DOWNLOAD THE PDF

Cover Story

Congress Plans to Accelerate Development of Drugs, Devices

By Matthew Bin Han Ong

The House Committee on Energy and Commerce is spearheading legislation aimed streamlining development of drugs and medical devices.

Research Advocates Prepare to Face Republican-led Congress

By Matthew Bin Han Ong

Half-Percent Raise Is Not Enough

Conversation with The Cancer Letter

Is Republican Control Better Than Two-Party Stalemate?

By Matthew Bin Han Ong

ACS President & COO Resigns Unexpectedly; Was Seen as Contender for CEO Position

By Paul Goldberg

ODAC To Advise FDA on First Biosimilars Application Jan. 7

NCI Board Approves Three Concepts

FDA Expands Cyramza Label to Include Metastatic NSCLC

Editorial

A Record-Breaking Year for The Cancer Letter

In Brief

Calvo Named Chief Scientific Officer of Cancer Core Europe

OSUCCC – James moves into new cancer hospital

MD Anderson and UnitedHealthcare launch bundled payment program

Ohio State University names 2014 James Hope Award winners

Washington University at St. Louis genome center receives $25 million pledge

George Washington University Cancer Institute receives $150,000 from Center for Advancing Health

Northwestern University’s Lurie Comprehensive Cancer Center enters research agreement with NeoGenomics Inc.

Oregon Health & Science University and FEI expand Living Lab for Cell Biology agreement

Cancer Treatment Centers of America select WIRB-Copernicus Group to help expand its clinical research program

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Volume 50 | Issue 43 - November 15, 2024

Congress Plans to Accelerate Development of Drugs, Devices

Research Advocates Prepare to Face Republican-led Congress

Half-Percent Raise Is Not Enough

Is Republican Control Better Than Two-Party Stalemate?

ACS President & COO Resigns Unexpectedly; Was Seen as Contender for CEO Position

ODAC To Advise FDA on First Biosimilars Application Jan. 7

NCI Board Approves Three Concepts

FDA Expands Cyramza Label to Include Metastatic NSCLC

A Record-Breaking Year for The Cancer Letter

In Brief

Calvo Named Chief Scientific Officer of Cancer Core Europe

OSUCCC – James moves into new cancer hospital

MD Anderson and UnitedHealthcare launch bundled payment program

Ohio State University names 2014 James Hope Award winners

Washington University at St. Louis genome center receives $25 million pledge

George Washington University Cancer Institute receives $150,000 from Center for Advancing Health

Northwestern University’s Lurie Comprehensive Cancer Center enters research agreement with NeoGenomics Inc.

Oregon Health & Science University and FEI expand Living Lab for Cell Biology agreement

Cancer Treatment Centers of America select WIRB-Copernicus Group to help expand its clinical research program

Recent Issues

Renew today!

Subscriber content

Login